{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:26:21Z","timestamp":1793384781120,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.semnephrol.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T16:09:21Z","timestamp":1623686961000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Diabetes and the Gut Microbiome"],"prefix":"10.1016","volume":"41","author":[{"given":"Wei Ling","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2021.03.005_bib0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrneph.2015.191","article-title":"The gut microbiome, diet, and links to cardiometabolic and chronic disorders","volume":"12","author":"Aron-Wisnewsky","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0002","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/CS20171107","article-title":"Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins","volume":"132","author":"Lau","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2018.10.063","article-title":"Interaction between gut microbiome and cardiovascular disease","volume":"214","author":"Peng","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0006","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2174\/138161208784480207","article-title":"Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease","volume":"14","author":"Isolauri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2011.11.007","article-title":"The dialog between microbiota and the immune system: shaping the partners through development and evolution","volume":"24","author":"Cerf-Bensussan","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Huttenhower C , Gevers D, Knight R, et\u00a0al, The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0009","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-011811-132421","article-title":"Human microbiome in health and disease","volume":"7","author":"Pflughoeft","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000381990","article-title":"The gut as a source of inflammation in chronic kidney disease","volume":"130","author":"Lau","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0012","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0013","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0014","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"104","author":"B\u00e4ckhed","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0015","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1038\/srep05922","article-title":"Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice","volume":"4","author":"Ellekilde","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0016","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0017","doi-asserted-by":"crossref","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00284-010-9582-9","article-title":"Molecular characterisation of the faecal microbiota in patients with type II diabetes","volume":"61","author":"Wu","year":"2010","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","article-title":"Intestinal microbiota in type 2 diabetes and chronic kidney disease","volume":"17","author":"Sabatino","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00592-019-01316-7","article-title":"Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition","volume":"56","author":"Tao","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000067","article-title":"Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study","volume":"3","author":"Simonsen","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0024","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-018-0620-2","article-title":"The human gut microbiome in early-onset type 1 diabetes from the TEDDY study","volume":"562","author":"Vatanen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/db12-0526","article-title":"Fecal microbiota composition differs between children with \u03b2-cell autoimmunity and those without","volume":"62","author":"de Goffau","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0026","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0027","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.celrep.2017.05.077","article-title":"The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue","volume":"19","author":"Schugar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial","volume":"68","author":"Heianza","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0029","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0030","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI94601","article-title":"l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans","volume":"129","author":"Koeth","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0033","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0034","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.metabol.2015.03.008","article-title":"A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus","volume":"64","author":"Kim","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41398-019-0552-0","article-title":"The effects of plant-based diets on the body and the brain: a systematic review","volume":"9","author":"Medawar","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0036","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0037","first-page":"12:1931","article-title":"Plant-dominant low-protein diet for conservative management of chronic kidney disease","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0038","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/nu11123006","article-title":"Effect of low-protein diet and inulin on microbiota and clinical parameters in patients with chronic kidney disease","volume":"11","author":"Lai","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0039","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4161\/gmic.1.4.12778","article-title":"Mucin-bacterial interactions in the human oral cavity and digestive tract","volume":"1","author":"Derrien","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0040","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0041","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0042","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2014-307142","article-title":"A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice","volume":"64","author":"Anh\u00ea","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0043","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-018-0708-x","article-title":"SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0044","doi-asserted-by":"crossref","first-page":"F824","DOI":"10.1152\/ajprenal.00314.2017","article-title":"Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model","volume":"315","author":"Mishima","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.diabet.2019.11.005","article-title":"Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: results of a double-blind randomized trial in patients with type 2 diabetes","volume":"46","author":"van Bommel","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0046","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","article-title":"Probiotics, prebiotics and synbiotics- a review","volume":"52","author":"Pandey","year":"2015","journal-title":"J Food Sci Technol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0047","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1586\/1744666X.2013.848793","article-title":"The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes","volume":"9","author":"Bekkering","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0048","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/microorganisms7030067","article-title":"Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives","volume":"7","author":"Mishra","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0049","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3945\/an.112.003046","article-title":"The interplay between fiber and the intestinal microbiome in the inflammatory response","volume":"4","author":"Kuo","year":"2013","journal-title":"Adv Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114881","article-title":"High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease","volume":"9","author":"Vaziri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0052","doi-asserted-by":"crossref","first-page":"F857","DOI":"10.1152\/ajprenal.00513.2015","article-title":"Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats","volume":"310","author":"Kieffer","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/hdi.12653","article-title":"Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial","volume":"22","author":"Tayebi Khosroshahi","year":"2018","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0054","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hdi.12753","article-title":"Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial","volume":"23","author":"Laffin","year":"2019","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0055","doi-asserted-by":"crossref","first-page":"e3213","DOI":"10.1002\/dmrr.3213","article-title":"Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials","volume":"36","author":"Tiderencel","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0056","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7569431","article-title":"Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment","volume":"2016","author":"Dolpady","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0057","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00125-019-4910-5","article-title":"Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice","volume":"62","author":"Hansen","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0058","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00394-017-1482-3","article-title":"Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats","volume":"57","author":"Tunapong","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0059","article-title":"Beneficial effect of symbiotic supplementation during pregnancy in high fat diet-induced metabolic disorder in rats: role of chemerin","volume":"19","author":"Amirpour","year":"2020","journal-title":"Obes Med"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0060","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.clnu.2018.08.009","article-title":"Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Sabico","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0061","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40200-017-0304-8","article-title":"Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial","volume":"16","author":"Ebrahimi","year":"2017","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0062","doi-asserted-by":"crossref","first-page":"68","DOI":"10.29252\/ibj.23.1.68","article-title":"The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"23","author":"Khalili","year":"2019","journal-title":"Iran Biomed J"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0063","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.dsx.2018.08.008","article-title":"The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: a randomized placebo controlled trial","volume":"13","author":"Razmpoosh","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0064","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12602-017-9343-1","article-title":"The effects of synbiotic supplementation on carotid intima-media thickness, biomarkers of inflammation, and oxidative stress in people with overweight, diabetes, and coronary heart disease: a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Farrokhian","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00394-016-1199-8","article-title":"Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial","volume":"56","author":"Firouzi","year":"2017","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0066","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","article-title":"Association of early exposure of probiotics and islet autoimmunity in the TEDDY study","volume":"170","author":"Uusitalo","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0067","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/jc.2019-00481","article-title":"Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes","volume":"104","author":"Ho","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0068","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/dc18-2248","article-title":"Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial","volume":"42","author":"Callaway","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0069","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/dc18-2591","article-title":"Efficacy of fish oil and\/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled, double-blind clinical trial","volume":"42","author":"Pellonper\u00e4","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jdi.12863","article-title":"Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: a double-blind randomized controlled trial","volume":"10","author":"Kijmanawat","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0071","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.diabet.2016.04.009","article-title":"Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Karamali","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0072","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejphar.2019.04.003","article-title":"The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"852","author":"Tabrizi","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2021.03.005_bib0073","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0074","first-page":"195","article-title":"[Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report]","volume":"66","author":"Zein","year":"2008","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.semnephrol.2021.03.005_bib0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41581-019-0142-7","article-title":"Gut microbial short-chain fatty acids and the risk of diabetes (editorial)","volume":"15","author":"Lau","year":"2019","journal-title":"Nat Rev Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952100036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952100036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:38:04Z","timestamp":1759448284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092952100036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S027092952100036X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.03.005","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and the Gut Microbiome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}